Crypto billionaire and bioengineer launch new anti-ageing start-up

By Monica Athnasious

Published Dec 15, 2021 at 12:21 PM

Reading time: 2 minutes

25585

Though the idea and historic human desire to ‘cure’ ageing has been a prevalent, unwavering topic in our scientific discussions, its virality spiralled following reports of resident billionaire Jeff Bezos funding the anti-ageing venture AltosLabs. Now, much like the billionaire boom in space—the latest being Yusaku Maezawa handing out cash off-planet—anti-ageing has become the new race among the rich. Enter NewLimit and its ambitious co-founders: crypto billionaire Brian Armstrong and bioengineer and tech investor Blake Byers. The company’s goal? To help us live foreverwell, more precisely, to greatly extend our human lifespan.

Often when we think of anti-ageing, our minds instantly conjure up superficial images of wrinkle-free, ageless faces—I mean, we are right in the middle of a boom of Botox after all—but the NewLimit co-founders have something different in mind. For Armstrong, CEO of Coinbase, and Byers, who has a PhD in bioengineering from Stanford University, the goal focuses on and prioritises the extension of healthspan as opposed to just lifespan. It’s aim? To improve quality of life in age-related health issues.

“Imagine if you could live the same number of years, but be free from pain, and have the same mobility and cognition as someone in their thirties. If we could maintain this state, how many of us would still want to have our lifespan end at the ‘normal’ time?” the founders stated in a press release last week. “Ageing is one of the largest sources of pain and suffering hiding in plain sight all around us, and we believe there is a moral imperative to try and end this suffering that affects every one of us,” they continued. But will it be available to all of us? We’ll get into that shortly, but first, let’s look at what you’re all here for—the tech.

Though the co-founders acknowledged that the pursuit to ‘cure’ ageing is “ambitious” and will likely take many, many decades to come to successful fruition (if possible), they’ve also added that it is imperative for them to start as soon as possible. NewLimit hopes to do this through epigenetics. But what is it? Epigenetics, as mentioned as part of the press release, is a phenomenon that began 15 years ago—a discovery which showed that “your cells are far more plastic than [previously] assumed.” With as little as four proteins, cells can be completely changed.

Input noted how the founders reference these claims from Nobel Prize-winning research, first published in 2006, that describes these four proteins as “Yamanaka factors” and uses them “to reprogram aged cells into immature cells—creating stem cells, the undifferentiated cells common in embryos, from the plain old issue in your body right now.” This is what NewLimit hopes to utilise in its aim to aid age-related health concerns and bring back the regenerative qualities of our bodies in youth.

“NewLimit plans to initially focus on this mechanism: epigenetic reprogramming. Put simply, we want to figure out a way to restore the regenerative potential we all had when we were younger, but somehow lost. The last year has emphasised this point on a global scale. We still do not know why the elderly have a weaker immune system and are more susceptible to infection and receive less protection from vaccines,” the founders claimed.

The company’s first steps to such programming is to develop the necessary “machine learning models” to understand what changes occur in our bodies with age and how they can be stopped or even reversed. 

Back to that very important question, will this be available to the everyday person or just for the Bezos billionaires of the world? Armstrong and Byers addressed this concern in the same press release. They claim that, like most state-of-the-art breakthrough advancements which often first come with a hefty price tag, the same will occur with NewLimit. However, overtime the cost of anything new drives down and becomes increasingly accessible to everyone. “Some of these products take decades to get to lower costs, but we hope to move much faster than that,” they stated.

The company is still in its infant stages, with its founding team yet to be completely formed. NewLimit is currently on the lookout for like-minded individuals interested in the pursuit and progression of biotech. Who knows? You could be that individual.

Keep On Reading

By Charlie Sawyer

Is Brooklyn Beckham feuding with his family? Rumours circulate after the chef skips his dad David Beckham’s 50th birthday

By Abby Amoakuh

I sat down with two professional matchmakers to solve Gen Z’s dating fatigue

By Eliza Frost

How Jet2holidays and Jess Glynne became the sound of the summer

By Charlie Sawyer

SHEIN faces fines from EU for deceiving customers with fake discounts and misleading information

By Charlie Sawyer

Will Greta Thunberg reach Gaza safely amid Israel’s aid blockade?

By Charlie Sawyer

Fans express concern after Harry Potter TV series announces the casting of Harry, Ron, and Hermione

By Eliza Frost

Louis Tomlinson opens up about Liam Payne’s death and reflects on One Direction’s 15th anniversary

By Charlie Sawyer

What is ketamine therapy, the psychiatric treatment healing famous Mormons Jen and Zac Affleck’s marriage?

By Eliza Frost

Black cat boyfriends are in to replace golden retriever boyfriends, but are they just emotionally unavailable men in disguise?

By Charlie Sawyer

President Trump and JD Vance angry over the DNC setting up a taco truck outside RNC headquarters

By Eliza Frost

Taylor Swift’s Release Party of a Showgirl is coming to cinemas everywhere, and it’s already made $15M

By Eliza Frost

The Summer I Turned Pretty stars Lola Tung and Gavin Casalegno caught in political drama

By Abby Amoakuh

John Lithgow fumbles JK Rowling question as Harry Potter TV show cast struggles with fan backlash

By Charlie Sawyer

Introducing Berlin’s latest tourist attraction Cybrothel, where men can request AI sex dolls covered in blood

By Eliza Frost

Rina Sawayama calls out Sabrina Carpenter’s SNL performance of Nobody’s Son for cultural insensitivity 

By Alma Fabiani

Amazon Music is giving away 4 months free. Here’s how to claim it

By Eliza Frost

Jennifer Aniston to star in Apple TV+ adaptation of Jennette McCurdy’s memoir I’m Glad My Mom Died

By Eliza Frost

American Eagle and Sydney Sweeney face backlash with employee’s LinkedIn post adding fuel to the fire

By Eliza Frost

What is the Gen Z stare, and why are millennials on TikTok so bothered by it?

By Charlie Sawyer

Transformers director Michael Bay officially confirmed to direct movie about viral Skibidi Toilet meme